CINRG randomized controlled trial of creatine and glutamine in Duchenne muscular dystrophy

Citations Over TimeTop 10% of 2005 papers

Abstract

We tested the efficacy and safety of glutamine (0.6 gm/kg/day) and creatine (5 gm/day) in 50 ambulant boys with Duchenne muscular dystrophy in a 6-month, double-blind, placebo-controlled clinical trial. Drug efficacy was tested by measuring muscle strength manually (34 muscle groups) and quantitatively (10 muscle groups). Timed functional tests, functional parameters, and pulmonary function tests were secondary outcome measures. Although there was no statistically significant effect of either therapy based on manual and quantitative measurements of muscle strength, a disease-modifying effect of creatine in older Duchenne muscular dystrophy and creatine and glutamine in younger Duchenne muscular dystrophy cannot be excluded. Creatine and glutamine were well tolerated.

Related Papers

• → Creatine and Creatinine in Tissues and Urine of Mice With Hereditary Muscular Dystrophy(1958)21 cited
• → CREATINE AND CREATININE METABOLISM IN PROGRESSIVE MUSCULAR DYSTROPHY(1932)14 cited
• [Delayed diagnosis of Duchenne muscular dystrophy in Chile].(1999)
• → EXCRETION OF 4-AMINO-5-IMIDAZOLECARBOXAMIDE AND CREATINE:CREATININE RATIOS IN HUMAN AND MOUSE MUSCULAR DYSTROPHY(1962)1 cited
• → Non-invasive tension-time-index and ventilator use in Duchenne muscular dystrophy(2008)